Swiss National Bank

Bank

Position in ACLX — Arcellx, Inc.

CIK 1582202 ZURICH, V8

Position in ACLX

as of Mar 31, 2026 · filed May 7, 2026 Compact

Position Value

$6,280,654

+$2,714,214 QoQ

Shares Held

54,700

0.0% QoQ

Ownership

0.094%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Swiss National Bank holds $1,640,558,253 across 148 Biotechnology names. ACLX ranks #40 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	744,600	$332,493,684
2	REGN	Regeneron Pharmaceuticals, Inc.	303,140	$234,218,089
3	ALNY	Alnylam Pharmaceuticals, Inc.	387,720	$128,284,916
4	INSM	INSMED Inc	625,912	$102,349,130
5	RPRX	Royalty Pharma plc	1,191,100	$57,137,067
6	INCY	Incyte Corp	489,774	$46,097,528
7	RVMD	Revolution Medicines, Inc.	425,431	$41,373,164
8	MRNA	Moderna, Inc.	696,100	$35,361,880

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$6,280,654	54,700	0.0%	Shares	Sole	2026-05-07
2025-12-31	$3,566,440	54,700	+2.4%	Shares	Sole	2026-02-12
2025-09-30	$4,384,140	53,400	-15.1%	Shares	Sole	2025-11-13
2025-06-30	$4,141,965	62,900	0.0%	Shares	Sole	2025-08-12
2025-03-31	$4,126,240	62,900	-0.8%	Shares	Sole	2025-05-12
2024-12-31	$4,862,146	63,400	+0.8%	Shares	Sole	2025-02-10
2024-09-30	$5,252,779	62,900	0.0%	Shares	Sole	2024-11-07
2024-06-30	$3,471,451	62,900	+11.5%	Shares	Sole	2024-08-08
2024-03-31	$3,922,620	56,400	-1.4%	Shares	Sole	2024-05-07
2023-12-31	$3,174,600	57,200	-9.6%	Shares	Sole	2024-02-06
2023-09-30	$2,271,204	63,300	+21.5%	Shares	Sole	2023-11-08
2023-06-30	$1,647,402	52,100	+57.4%	Shares	Sole	2023-08-09
2023-03-31	$1,019,811	33,100	-10.5%	Shares	Sole	2023-05-10
2022-12-31	$1,146,260	37,000	—	Shares	Sole	2023-02-08
No filing history on record for this holder in this stock.